Antimalarials in rheumatic diseases.

Antimalarials in rheumatic diseases.

Item
http://www.wikidata.org/entity/Q37799076
Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors.Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.Influence of hydroxychloroquine on the bioavailability of oral metoprololLife Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine.Psychomotor Agitation Following Treatment with Hydroxychloroquine.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation.
P2860

Antimalarials in rheumatic diseases.

Item
http://www.wikidata.org/entity/Q37799076
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimalarials in rheumatic diseases.
@en
Antimalarials in rheumatic diseases.
@nl
type
label
Antimalarials in rheumatic diseases.
@en
Antimalarials in rheumatic diseases.
@nl
prefLabel
Antimalarials in rheumatic diseases.
@en
Antimalarials in rheumatic diseases.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Antimalarials in rheumatic diseases.
@en
P2093
P304
P31
P356
10.1016/S0950-3579(05)80004-4
P433
P478
P577
P698
P921